Exor N.V. acquires 45% of Lifenet Healthcare

Exor N.V. (“Exor”), a leading diversified holding company controlled by the Agnelli family, has signed an agreement to acquire a 45% shareholding in Lifenet S.r.l. (“Lifenet Healthcare” or “the Company”), an Italian company active in the healthcare sector, particularly in the management of hospitals and outpatient clinics. The transaction, which will be executed principally via a capital increase reserved for Exor and the concurrent acquisition of shares owned by Invin S.r.l., the company that controls Lifenet, entails a total investment by Exor of €67 million.

Exor launches Italy Seeds Program to back the most promising entrepreneurs in the country

Exor announces the launch of an Italy-focused seed initiative to support the country’s most promising entrepreneurs building the next generation of great companies. Exor Seeds (early stage venture arm of Exor) will invest in pre-seed and seed stage startups offering a €150K investment with an efficient diligence process, founder-friendly terms, and no board seat.

Exor and Covéa sign a Definitive Agreement for the sale of PartnerRe for $9 Billion (€7.8 Billion)

The closing of the transaction is expected in mid-2022

Transaction will reinforce PartnerRe’s strategy, further confirming its status as one of the world’s leading reinsurers

Exor and Covéa to expand their reinsurance and investment cooperation

Paris and Amsterdam, 16 December 2021. Covéa, a leading French mutual insurer and Exor, the leading diversified holding company controlled by the Agnelli family, have signed, following the completion of the required consultation with wor

Subscribe to